Aging and hospitalization - L9 Flashcards
Name hallmarks of aging.
- Loss of proteostasis
- Epigenetic alterations
- Telomere attrition
- Genomic instability
- Altered intracellular communication
- Stem cell exhaustion
- Cellular senescence
- Mitochondrial dysfunction
- Dysregulated nutrient sensing
What is sarcopenia?
The age-related loss of muscle mass and function (strength)
What is the difference between primary sarcopenia and secondary sarcopenia?
- Primary sarcopenia is due to aging
- Secondary sarcopenia is due to inactivity, malnutrition, or illness-related.
Describe in short the pathophysiology of sarcopenia.
- Lifestyle changes such as decreased physical activity lead to hormonal changes.
- Hormonal changes such as the decrease in sex hormones lead to sarcopenia.
- Lifestyle changes such as decreased physical activity also lead to decreased fibre size and amount of satellite cells.
- Inflammation indirectly leads to sarcopenia by influencing fibre size and amounto of satellite cells and by influencing the amount of motor units and fiber numbers.
- Motorneuron death indirectly leads to sarcopenia by decreasing the amount of motor units and fiber numbers, which lead to sarcopenia.
Age determines muscle size. What can be an explanation of this?
More inflammatory cytokines in aging (inflammaging).
What inflammatory markers have been found to be associated with aging?
- TNF-a expression is higher in muscles from elderly people.
- Higher IL-6 and CRP are associated with poorer physical performance and poorer cognitive performance.
What is immunosenescence?
Remodelling of the immune system with age, where there is loss of immune functions leading to a decline in immunity.
Name consequences of immunosenescence.
- Lower lymphocyte number responding to new antigens
- T cell response to antigens slowed down
- Macrophages destroy bacteria, cancer cells and other antigens less quickly (possibly contributing to increased incidence of cancer among elderly)
- Complement system produces less plasma proteins in response to bacterial infections
- Immune system becomes less able to distinguish self from nonself, making auto-immune disorders more common
- Less antibodies produced in response to antigen
- Antibodies are less efficient in binding to antigens.
- Vaccines less effective
- Higher risk and incidence of disease such as pneumonia and influenza
Describe the effect of immunosenescence on the function of the following immune cells:
- T lymphocytes
- B lymphocytes
- Macrophages
- Mast cells
- NK cells
- Neutrophils
- T lymphocytes: increased memore CD8+ T cells and decreased naive CD4+ T cells
- B lymphocytes: decreased B-cell production
- Macrophages: decreased phagocytosis and increased inflammatory cytokine production
- Mast cells: decreased mast cell production and increased mast cell degranulation
- NK cells: decreased cytotoxicity and IL-2 production
- Neutrophils: decreased chemotaxis, free radical production and apoptosis
Context information:
- 30% of elderly experience at least one fall yearly
- 10% of falls result in fracture
- 1% of falls result in hip fractures
- Increased mortality
- Risk factor for falls: lower extremity weakness
What is associated with NLRP3 inflammasome activation?
Metabolic and morphological alterations in skeletal muscle
- What is the relationship between NLRP3 and LPS?
- What is the relationship between IL-1β and LPS?
- NLRP3 activation responds in a dose-dependent manner to LPS. The more LPS (i.e. inflammation), the more NLRP3 is activated.
- Since IL-1β is produced as a result of NLRP3 activation and subsequent production of caspase-1 that cleaves pro-IL-1β into IL-1β, IL1β can be linked to exposure of LPS.
What relationship exists between myotube diameter and LPS levels?
- 0 ng/ml LPS is associated with an increasing myotube diameters, whereas 100 ng/ml LPS is associated with a reduced increase in myotube diameter.
- When LPS is combined with a pharmacological inhibitor of NLRP3‐induced IL‐1β production (MCC950), this leads to an average increase in myotube diameter. Suggesting that IL-1β is crucial in the morphological and metabolic changes in skeletal muscle upon NLRP3 inflammasome activation.
What association exists between NLRP3 and mitochondria?
A study used immunostaining for SDHA (subunit of mitochondrial complex II) and NLRP3 to identify mitochondrial localization of LRP3 in vehicle-treated myotubes. Upon LPS exposure, more NLRP3 associated with mitochondria, shown by increasing colocalization between NLRP3 and SDHA.
What happened to oxygen consumption and acidification rate (glycolytic rates) (measures of mitochondrial metabolism) in myotubes exposed to LPS?
Exposure to LPS resulted in a higher oxygen consumption and a higher acidification rate.